Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Associations between housing stability and injecting frequency fluctuations: findings from a cohort of people who inject drugs in Montréal, Canada.

Fortier E, Sylvestre MP, Artenie AA, Minoyan N, Jutras-Aswad D, Roy É, Grebely J, Bruneau J.

Drug Alcohol Depend. 2019 Nov 17;206:107744. doi: 10.1016/j.drugalcdep.2019.107744. [Epub ahead of print]

PMID:
31785537
2.

Adapting the Canadian CT head rule age criteria for mild traumatic brain injury.

Fournier N, Gariepy C, Prévost JF, Belhumeur V, Fortier É, Carmichael PH, Gariepy JL, Le Sage N, Émond M.

Emerg Med J. 2019 Oct;36(10):617-619. doi: 10.1136/emermed-2018-208153. Epub 2019 Jul 20.

PMID:
31326953
3.

Shewanella decolorationis LDS1 Chromate Resistance.

Lemaire ON, Honoré FA, Tempel S, Fortier EM, Leimkühler S, Méjean V, Iobbi-Nivol C.

Appl Environ Microbiol. 2019 Aug 29;85(18). pii: e00777-19. doi: 10.1128/AEM.00777-19. Print 2019 Sep 15.

4.

Facts and Fears in Public Reporting: Patients' Information Needs and Priorities When Selecting a Hospital for Cancer Care.

Chimonas S, Fortier E, Li DG, Lipitz-Snyderman A.

Med Decis Making. 2019 Aug;39(6):632-641. doi: 10.1177/0272989X19855050. Epub 2019 Jun 21.

PMID:
31226909
5.

Association between mental health service utilisation and sharing of injection material among people who inject drugs in Montreal, Canada.

Côté P, Ghabrash MF, Bruneau J, Roy É, Dubreucq S, Fortier E, Jutras-Aswad D.

Addict Behav. 2019 Sep;96:175-182. doi: 10.1016/j.addbeh.2019.05.010. Epub 2019 May 13.

PMID:
31108263
6.

Testosterone deficiency reduces cardiac hypertrophy in a rat model of severe volume overload.

Beaumont C, Walsh-Wilkinson É, Drolet MC, Roussel É, Melançon N, Fortier É, Harpin G, Beaudoin J, Arsenault M, Couet J.

Physiol Rep. 2019 May;7(9):e14088. doi: 10.14814/phy2.14088.

7.

The spectrum of facial palsy: The MEEI facial palsy photo and video standard set.

Greene JJ, Guarin DL, Tavares J, Fortier E, Robinson M, Dusseldorp J, Quatela O, Jowett N, Hadlock T.

Laryngoscope. 2019 Apr 25. doi: 10.1002/lary.27986. [Epub ahead of print]

PMID:
31021433
8.

Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada.

Fortier E, Artenie AA, Zang G, Jutras-Aswad D, Roy É, Grebely J, Bruneau J.

Addiction. 2019 Aug;114(8):1495-1503. doi: 10.1111/add.14632. Epub 2019 May 28.

PMID:
30957310
9.

Know your limits: RPA availability and chemoresistance in ovarian cancer.

Fortier E, Drobetsky E, Wurtele H.

Oncotarget. 2019 Jan 25;10(8):800-802. doi: 10.18632/oncotarget.26607. eCollection 2019 Jan 25. No abstract available.

10.

An open-source algorithm for rapid unbiased determination of DNA fiber length.

Ghesquière P, Elsherbiny A, Fortier E, McQuaid M, Mazzaferri J, Bélanger F, Cheriet F, Drobetsky E, Wurtele H, Costantino S.

DNA Repair (Amst). 2019 Feb;74:26-37. doi: 10.1016/j.dnarep.2019.01.003. Epub 2019 Jan 11.

PMID:
30665830
11.

Incorporating Multiple Perspectives Into the Development of an Electronic Survivorship Platform for Head and Neck Cancer.

Salz T, Schnall RB, McCabe MS, Oeffinger KC, Corcoran S, Vickers AJ, Salner AL, Dornelas E, Raghunathan NJ, Fortier E, McKiernan J, Finitsis DJ, Chimonas S, Baxi S.

JCO Clin Cancer Inform. 2018 Dec;2:1-15. doi: 10.1200/CCI.17.00105.

12.

Automating Treatment Summary Development Using Electronic Billing Information: A Pilot Study of Survivors of Head and Neck Cancer.

Baxi SS, Sukhu R, Fortier E, Oeffinger K, Corcoran S, Salner A, Vickers AJ, McCabe MS, Salz T.

J Oncol Pract. 2019 Jan;15(1):e84-e90. doi: 10.1200/JOP.18.00022. Epub 2018 Dec 3.

PMID:
30523752
13.

Radical Prostatectomy after Vascular Targeted Photodynamic Therapy with Padeliporfin: Feasibility, and Early and Intermediate Results.

Pierrard V, Lebdai S, Kleinclauss F, Azzouzi AR, Terrier JE, Fortier E, Joniau S, Van Der Poel H, Salomon G, Casanova J, Medina-Lopez RA, Potiron E, Rigaud J, Vincendeau S, Rassweiler J, Villers A, Gaston R, Saussine C, Giai J, Gaillac B, Emberton M, Ruffion A.

J Urol. 2019 Feb;201(2):315-321. doi: 10.1016/j.juro.2018.08.084.

PMID:
30248343
14.

Replication Protein A Availability during DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells.

Bélanger F, Fortier E, Dubé M, Lemay JF, Buisson R, Masson JY, Elsherbiny A, Costantino S, Carmona E, Mes-Masson AM, Wurtele H, Drobetsky E.

Cancer Res. 2018 Oct 1;78(19):5561-5573. doi: 10.1158/0008-5472.CAN-18-0618. Epub 2018 Aug 2.

15.

Risk Factors for Adverse Events in Patients With Breast, Colorectal, and Lung Cancer.

Weingart SN, Atoria CL, Pfister D, Classen D, Killen A, Fortier E, Epstein AS, Anderson C, Lipitz-Snyderman A.

J Patient Saf. 2018 Feb 6. doi: 10.1097/PTS.0000000000000474. [Epub ahead of print]

16.

Exploring young mothers' experiences with postpartum contraception in Ottawa: results from a multimethods qualitative study.

Fortier E, Foster AM.

Contraception. 2018 May;97(5):434-438. doi: 10.1016/j.contraception.2017.12.017. Epub 2018 Jan 8.

PMID:
29326036
17.

Benefits of Urologic-Dermatologic Consultations for the Diagnosis of Cutaneous Penile Lesions: A Prospective Study.

Fortier E Jr, Cerruti A, Clec'h CL, Azzouzi AR, Bigot P.

Clin Genitourin Cancer. 2018 Apr;16(2):e421-e424. doi: 10.1016/j.clgc.2017.09.013. Epub 2017 Oct 5.

PMID:
29079166
18.

Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum.

Lipitz-Snyderman A, Pfister D, Classen D, Atoria CL, Killen A, Epstein AS, Anderson C, Fortier E, Weingart SN.

Cancer. 2017 Dec 1;123(23):4728-4736. doi: 10.1002/cncr.30916. Epub 2017 Aug 17.

19.

High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.

Puzhko S, Roy É, Jutras-Aswad D, Artenie AA, Fortier E, Zang G, Bruneau J.

Int J Drug Policy. 2017 Sep;47:61-68. doi: 10.1016/j.drugpo.2017.05.027. Epub 2017 Jun 27.

PMID:
28666636
20.

Peers without fears? Barriers to effective communication among primary care physicians and oncologists about diagnostic delays in cancer.

Lipitz-Snyderman A, Kale M, Robbins L, Pfister D, Fortier E, Pocus V, Chimonas S, Weingart SN.

BMJ Qual Saf. 2017 Nov;26(11):892-898. doi: 10.1136/bmjqs-2016-006181. Epub 2017 Jun 27.

21.

Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection.

Artenie AA, Zang G, Daniel M, Fortier E, Jutras-Aswad D, Puzhko S, Bruneau J.

Int J Drug Policy. 2017 Sep;47:239-243. doi: 10.1016/j.drugpo.2017.05.033. Epub 2017 Jun 4.

PMID:
28587944
22.

Performance of a Trigger Tool for Identifying Adverse Events in Oncology.

Lipitz-Snyderman A, Classen D, Pfister D, Killen A, Atoria CL, Fortier E, Epstein AS, Anderson C, Weingart SN.

J Oncol Pract. 2017 Mar;13(3):e223-e230. doi: 10.1200/JOP.2016.016634. Epub 2017 Jan 17.

23.

A head and neck cancer intervention for use in survivorship clinics: a protocol for a feasibility study.

Salz T, McCabe MS, Oeffinger KC, Corcoran S, Vickers AJ, Salner AL, Dornelas E, Schnall R, Raghunathan NJ, Fortier E, Baxi SS.

Pilot Feasibility Stud. 2016 May 5;2:23. eCollection 2016.

24.

Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia.

Fortier E, Alavi M, Bruneau J, Micallef M, Perram J, Sockalingam S, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ, Grebely J; ETHOS Study Group.

J Addict Med. 2017 Jan/Feb;11(1):10-18. doi: 10.1097/ADM.0000000000000261.

PMID:
27775955
25.

[The room of errors, fun and pedagogical].

Oriol P, Fortier É, Grenier D.

Rev Infirm. 2016 May;221:33-4. doi: 10.1016/j.revinf.2016.02.014. French.

PMID:
27155276
26.

ReCAP: Detection of Potentially Avoidable Harm in Oncology From Patient Medical Records.

Lipitz-Snyderman A, Weingart SN, Anderson C, Epstein AS, Killen A, Classen D, Sima CS, Fortier E, Atoria CL, Pfister D, Lipitz-Snyderman A, Weingart SN, Anderson C, Epstein AS, Killen A, Classen D, Sima CS, Fortier E, Atoria CL, Pfister D.

J Oncol Pract. 2016 Feb;12(2):178-9; e224-30. doi: 10.1200/JOP.2015.006874.

27.

Mutations in Replicative Stress Response Pathways Are Associated with S Phase-specific Defects in Nucleotide Excision Repair.

Bélanger F, Angers JP, Fortier É, Hammond-Martel I, Costantino S, Drobetsky E, Wurtele H.

J Biol Chem. 2016 Jan 8;291(2):522-37. doi: 10.1074/jbc.M115.685883. Epub 2015 Nov 17.

28.

[Coordination of hospital surveillance].

Fortier É, Oriol P.

Soins. 2015 Jun;Spec No:2S22. French. No abstract available.

PMID:
26506724
29.

The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study.

Fortier E, Alavi M, Micallef M, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ, Bruneau J, Grebely J; ETHOS Study Group.

Int J Drug Policy. 2015 Nov;26(11):1094-102. doi: 10.1016/j.drugpo.2015.06.001. Epub 2015 Jun 11.

PMID:
26145482
30.

Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study.

Alavi M, Micallef M, Fortier E, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ, Grebely J; ETHOS Study Group.

J Viral Hepat. 2015 Nov;22(11):914-25. doi: 10.1111/jvh.12415. Epub 2015 May 21.

PMID:
25996567
31.

The design and implementation of a generic lipopeptide scanning platform to enable the identification of 'locally acting' agonists for the apelin receptor.

McKeown SC, Zecri FJ, Fortier E, Taggart A, Sviridenko L, Adams CM, McAllister KH, Pin SS.

Bioorg Med Chem Lett. 2014 Oct 15;24(20):4871-5. doi: 10.1016/j.bmcl.2014.08.045. Epub 2014 Aug 28.

PMID:
25241924
32.

Spirocyclic acylphloroglucinol derivatives from Hypericum pyramidatum.

Force R, Chen SL, Fortier E, Rowlands E, Heneks J, Rovnyak D, Henry GE.

Nat Prod Commun. 2014 Jul;9(7):961-4.

PMID:
25230504
33.

Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: a brain stimulation reward study.

Gallo A, Bouchard C, Fortier E, Ducrot C, Rompré PP.

Eur Neuropsychopharmacol. 2014 Sep;24(9):1534-45. doi: 10.1016/j.euroneuro.2014.07.003. Epub 2014 Jul 19.

PMID:
25092427
34.

Opposite modulation of brain stimulation reward by NMDA and AMPA receptors in the ventral tegmental area.

Ducrot C, Fortier E, Bouchard C, Rompré PP.

Front Syst Neurosci. 2013 Oct 3;7:57. doi: 10.3389/fnsys.2013.00057. eCollection 2013.

35.

Circadian variation of the response of T cells to antigen.

Fortier EE, Rooney J, Dardente H, Hardy MP, Labrecque N, Cermakian N.

J Immunol. 2011 Dec 15;187(12):6291-300. doi: 10.4049/jimmunol.1004030. Epub 2011 Nov 9.

36.

Altered patterns of brain activity during transient sadness in children at familial risk for major depression.

Lévesque ML, Beauregard M, Ottenhof KW, Fortier E, Tremblay RE, Brendgen M, Pérusse D, Dionne G, Robaey P, Vitaro F, Boivin M, Booij L.

J Affect Disord. 2011 Dec;135(1-3):410-3. doi: 10.1016/j.jad.2011.08.010. Epub 2011 Sep 3.

PMID:
21890212
37.

Early influence of the rs4675690 on the neural substrates of sadness.

Fortier E, Noreau A, Lepore F, Boivin M, Pérusse D, Rouleau GA, Beauregard M.

J Affect Disord. 2011 Dec;135(1-3):336-40. doi: 10.1016/j.jad.2011.06.039. Epub 2011 Jul 31.

PMID:
21807415
38.

Early impact of 5-HTTLPR polymorphism on the neural correlates of sadness.

Fortier E, Noreau A, Lepore F, Boivin M, Pérusse D, Rouleau GA, Beauregard M.

Neurosci Lett. 2010 Nov 26;485(3):261-5. doi: 10.1016/j.neulet.2010.09.026. Epub 2010 Sep 17.

PMID:
20851164
39.

SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells.

Nasrin N, Wu X, Fortier E, Feng Y, Bare' OC, Chen S, Ren X, Wu Z, Streeper RS, Bordone L.

J Biol Chem. 2010 Oct 15;285(42):31995-2002. doi: 10.1074/jbc.M110.124164. Epub 2010 Aug 4.

40.

JNK1 phosphorylates SIRT1 and promotes its enzymatic activity.

Nasrin N, Kaushik VK, Fortier E, Wall D, Pearson KJ, de Cabo R, Bordone L.

PLoS One. 2009 Dec 22;4(12):e8414. doi: 10.1371/journal.pone.0008414.

41.

Clock-dependent and independent transcriptional control of the two isoforms from the mouse Rorgamma gene.

Mongrain V, Ruan X, Dardente H, Fortier EE, Cermakian N.

Genes Cells. 2008 Dec;13(12):1197-210. doi: 10.1111/j.1365-2443.2008.01237.x.

42.

Involvement of protein kinase Czeta in interleukin-1beta induction of ADAMTS-4 and type 2 nitric oxide synthase via NF-kappaB signaling in primary human osteoarthritic chondrocytes.

Chockalingam PS, Varadarajan U, Sheldon R, Fortier E, LaVallie ER, Morris EA, Yaworsky PJ, Majumdar MK.

Arthritis Rheum. 2007 Dec;56(12):4074-83.

43.

Alternative methods for genetic transformation of Pseudozyma antarctica, a basidiomycetous yeast-like fungus.

Marchand G, Fortier E, Neveu B, Bolduc S, Belzile F, Bélanger RR.

J Microbiol Methods. 2007 Sep;70(3):519-27. Epub 2007 Jul 3.

PMID:
17669528
44.

Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling.

Bhat BM, Allen KM, Liu W, Graham J, Morales A, Anisowicz A, Lam HS, McCauley C, Coleburn V, Cain M, Fortier E, Bhat RA, Bex FJ, Yaworsky PJ.

Gene. 2007 Apr 15;391(1-2):103-12. Epub 2006 Dec 29.

PMID:
17276019
45.
46.

Targeted expression of dominant negative proteasome mutants in Drosophila melanogaster.

Belote JM, Fortier E.

Genesis. 2002 Sep-Oct;34(1-2):80-2. No abstract available.

PMID:
12324954
47.

Temperature-dependent gene silencing by an expressed inverted repeat in Drosophila.

Fortier E, Belote JM.

Genesis. 2000 Apr;26(4):240-4. Erratum in: Genesis;2000 May;27(1):48.

PMID:
10748461
48.

Oxygen therapy for the premature infant.

Fortier EG.

Arch Ophthalmol. 1968 Apr;79(4):506-7. No abstract available.

PMID:
5640329
49.

EMERGENCY OPERATIONS AT PROVIDENCE HOSPITAL. MARCH 27, 5:30 P.M.--MARCH 29, 5:30 P.M.

FORTIER E.

Alaska Med. 1964 Jun;6:57-64. No abstract available.

PMID:
14156511
50.

HOW PROVIDENCE HOSPITAL WITHSTOOD THE QUAKE ORDEAL.

FORTIER E.

Hosp Prog. 1964 May;45:8 PASSIM. No abstract available.

PMID:
14143850

Supplemental Content

Loading ...
Support Center